Substance Use in Assault-Injured Young Adults
Launched by YALE UNIVERSITY · Jul 8, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at ways to better support young adults who have been hurt in an assault and also use alcohol or cannabis. The goal is to improve a short, motivating conversation that takes place in the emergency room to help these young people feel more confident about making positive changes in their alcohol and cannabis use. Researchers will also explore how friends and family might influence their habits and involvement in violence. The team will use a careful, step-by-step process to test and adapt this conversation to make it more helpful.
To join the study, participants need to be between 18 and 25 years old, speak English, and have recently been injured by someone who is not a boyfriend, girlfriend, fiancé, or spouse. They must also currently misuse alcohol or cannabis and be able to give consent to participate. People who are actively suicidal, seriously mentally impaired, involved in addiction treatment, in police custody, or who were hurt by a partner or in a sexual assault won’t be eligible. If you take part, you will be asked to share your experiences through interviews and surveys and might take part in the improved conversation during your emergency room visit. This study has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Aim 1:
- • Be clients of the Yale Hospital Violence Intervention Program (YHVIP)
- • Be between the ages of 18-25 y/o upon study enrollment
- • Have sustained an intentional injury inflicted by another person not considered to be a boy/girlfriend, fiancée, or spouse in the past year
- • Report current alcohol and/or cannabis misuse
- • Be English-speaking and able to provide informed consent.
- Aim 2 and 3:
- • Present to Yale New Haven Hospital ED for an intentional injury inflicted by another person not considered to be a boy/girlfriend, fiancée, or spouse
- • Be between the ages of 18-25 y/o upon study enrollment
- • Report current alcohol and/or cannabis misuse
- • Be English-speaking and able to provide informed consent.
- Exclusion Criteria:
- Aim 1:
- • Be actively suicidal or severely cognitively impaired precluding informed consent
- • Sustain an intentional injury from a boy/girlfriend, fiancée, or spouse or sexual assault
- • Be incarcerated or in police custody
- • Currently engaged in addiction treatment
- Aim 2 and 3:
- • Be actively suicidal or severely cognitively impaired precluding informed consent
- • Sustain intentional injury from a boy/girlfriend, fiancée, spouse or by sexual assault
- • Be incarcerated or in police custody
- • Currently engaged in addiction treatment
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Edouard Coupet, MD, MS
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported